• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺眼病(TED)眼睑退缩的非手术治疗

Non-surgical treatment for eyelid retraction in thyroid eye disease (TED).

作者信息

Grisolia Ana Beatriz Diniz, Couso Ricardo Christopher, Matayoshi Suzana, Douglas Raymond S, Briceño César Augusto

机构信息

Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Scheie Eye Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

出版信息

Br J Ophthalmol. 2017 Aug 9. doi: 10.1136/bjophthalmol-2017-310695.

DOI:10.1136/bjophthalmol-2017-310695
PMID:28794075
Abstract

Thyroid eye disease (TED) is an autoimmune condition with an unpredictable course that may lead to permanent facial disfigurement. Eyelid retraction is one of the most common findings, and frequently demands attention due to ocular exposure and impaired cosmesis. Surgical treatment remains the most effective option, but there is a role for temporary corrections during the active phase of the disease, as well as in patients who are poor surgical candidates. The aim of this review is to describe the non-surgical modalities currently available for treatment of eyelid malposition in TED. The authors have focused on the use of hyaluronic acid, triamcinolone injections and botulinum toxin type A as non-surgical treatment alternatives, paying special attention to dosing, technique, efficacy and duration of effect. Non-surgical treatment modalities may represent viable in cases where surgical correction is not an option. Although temporary, these modalities appear to be beneficial for ocular exposure remediation, improving quality of life and broadening our therapeutic arsenal.

摘要

甲状腺眼病(TED)是一种自身免疫性疾病,病程不可预测,可能导致永久性面部毁容。眼睑退缩是最常见的表现之一,常因眼球暴露和美容受损而备受关注。手术治疗仍然是最有效的选择,但在疾病活动期以及手术候选不佳的患者中,临时矫正也有作用。本综述的目的是描述目前可用于治疗TED中眼睑位置异常的非手术方法。作者重点关注透明质酸、曲安奈德注射和A型肉毒杆菌毒素作为非手术治疗选择的应用,特别关注给药剂量、技术、疗效和效果持续时间。在无法进行手术矫正的情况下,非手术治疗方法可能是可行的。尽管这些方法是临时性的,但它们似乎有助于改善眼球暴露情况,提高生活质量,并拓宽我们的治疗手段。

相似文献

1
Non-surgical treatment for eyelid retraction in thyroid eye disease (TED).甲状腺眼病(TED)眼睑退缩的非手术治疗
Br J Ophthalmol. 2017 Aug 9. doi: 10.1136/bjophthalmol-2017-310695.
2
Management of eyelid retraction related to thyroid eye disease.甲状腺眼病相关眼睑退缩的管理
Taiwan J Ophthalmol. 2022 Feb 14;12(1):12-21. doi: 10.4103/tjo.tjo_57_21. eCollection 2022 Jan-Mar.
3
A review of surgical techniques to correct upper eyelid retraction associated with thyroid eye disease.甲状腺相关眼病伴上睑退缩的手术治疗方法综述。
Curr Opin Ophthalmol. 2011 Sep;22(5):391-3. doi: 10.1097/ICU.0b013e3283499433.
4
Eyelid Surgery in Thyroid Eye Disease.甲状腺眼病的眼睑手术。
Ophthalmic Plast Reconstr Surg. 2023 Dec 1;39(6S):S92-S104. doi: 10.1097/IOP.0000000000002543. Epub 2023 Dec 4.
5
[Triamcinolone acetonide deep fornix injection for the treatment of upper eyelid retraction in patients with thyroid-associated ophthalmopathy].曲安奈德深穹窿注射治疗甲状腺相关眼病患者上睑退缩
Zhonghua Yan Ke Za Zhi. 2020 Jul 11;56(7):524-529. doi: 10.3760/cma.j.cn112142-20191009-00504.
6
Epidemiological Status of Thyroid Eye Disease in Central Iran.伊朗中部甲状腺眼病的流行病学状况
J Curr Ophthalmol. 2022 Apr 16;34(1):106-111. doi: 10.4103/joco.joco_223_21. eCollection 2022 Jan-Mar.
7
Clinical efficacy of transcutaneous triamcinolone acetonide injection for upper eyelid retraction and swelling in patients with thyroid eye disease.曲安奈德经皮注射治疗甲状腺眼病患者上睑退缩和肿胀的临床疗效
Int Med Case Rep J. 2018 Nov 9;11:325-331. doi: 10.2147/IMCRJ.S177671. eCollection 2018.
8
Thyroid eye disease reactivation associated with COVID-19 vaccination.与新冠病毒疫苗接种相关的甲状腺眼病复发
Taiwan J Ophthalmol. 2022 Feb 28;12(1):93-96. doi: 10.4103/tjo.tjo_61_21. eCollection 2022 Jan-Mar.
9
Hyaluronic acid gel injection for upper eyelid retraction in thyroid eye disease: functional and dynamic high-resolution ultrasound evaluation.透明质酸凝胶注射治疗甲状腺眼病上睑退缩:功能及动态高分辨率超声评估
Ophthalmic Plast Reconstr Surg. 2014 Sep-Oct;30(5):400-4. doi: 10.1097/IOP.0000000000000130.
10
[Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].[甲状腺眼病的发病机制——针对促甲状腺激素受体的自身免疫能解释所有病例吗?]
Endokrynol Pol. 2011;62 Suppl 1:1-7.

引用本文的文献

1
Triamcinolone acetonide and botulinum toxin A for upper eyelid retraction in thyroid-associated ophthalmopathy.曲安奈德和A型肉毒杆菌毒素用于甲状腺相关性眼病上睑退缩的治疗
Sci Rep. 2025 Feb 11;15(1):5103. doi: 10.1038/s41598-025-89063-4.
2
Nonsurgical management of upper eyelid retraction in thyroid eye disease.甲状腺眼病上睑退缩的非手术治疗
Taiwan J Ophthalmol. 2023 May 23;14(4):548-553. doi: 10.4103/tjo.TJO-D-23-00043. eCollection 2024 Oct-Dec.
3
Management of Graves' upper eyelid retraction (GUER): A review.格雷夫斯病上睑退缩的管理:综述
Indian J Ophthalmol. 2025 Feb 1;73(2):164-172. doi: 10.4103/IJO.IJO_748_24. Epub 2024 Dec 27.
4
Extraocular Muscle Enlargement in Thyroid Eye Disease Using Volumetric Analysis.甲状腺眼病中眼外肌增大的容积分析
Cureus. 2024 Jul 4;16(7):e63843. doi: 10.7759/cureus.63843. eCollection 2024 Jul.
5
Thyroid Eye Disease: Advancements in Orbital and Ocular Pathology Management.甲状腺眼病:眼眶及眼部病理学管理的进展
J Pers Med. 2024 Jul 22;14(7):776. doi: 10.3390/jpm14070776.
6
Percutaneous triamcinolone injection for upper eyelid retraction in thyroid eye disease.经皮注射曲安奈德治疗甲状腺眼病上睑退缩
Front Ophthalmol (Lausanne). 2024 May 17;4:1388197. doi: 10.3389/fopht.2024.1388197. eCollection 2024.
7
Multidisciplinary approach to orbital decompression. A review.眼眶减压的多学科方法。综述。
Acta Otorhinolaryngol Ital. 2021 Apr;41(Suppl. 1):S90-S101. doi: 10.14639/0392-100X-suppl.1-41-2021-09.
8
Injectable bio-responsive hydrogel for therapy of inflammation related eyelid diseases.用于治疗炎症相关眼睑疾病的可注射生物响应水凝胶。
Bioact Mater. 2021 Mar 9;6(10):3062-3073. doi: 10.1016/j.bioactmat.2021.02.040. eCollection 2021 Oct.
9
Thyroid Eye Disease-Related Epiblepharon: A Comparative Case Study.甲状腺眼病相关的内眦赘皮:一项对比性病例研究。
Asia Pac J Ophthalmol (Phila). 2020 Jan-Feb;9(1):44-47. doi: 10.1097/01.APO.0000617916.50176.b2.